Imiquad Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Imiquimod

Indications/Uses

Clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults; biopsy-confirmed, primary superficial basal cell carcinoma (sBCC) in immunocompetent adults. External genital & perianal warts/condyloma acuminata in patients >12 yr.

Click to view Imiquad detailed prescribing information

Dosage/Direction for Use

Actinic keratosis Apply 2 times/wk for full 16 wk to a defined treatment area. Superficial basal cell carcinoma 5 times/wk for a full 6 wk to the affected area. External genital warts 3 times/wk to affected area, continue until there is total clearance of the genital/perianal warts or max of 16 wk.

Click to view Imiquad detailed prescribing information

Overdosage

View Imiquad overdosage for action to be taken in the event of an overdose.

Special Precautions

May exacerbate inflammatory conditions of the skin, including chronic graft versus host disease. Discontinue for severe vulvar swelling. Consider interruption of dosing if systemic reactions occur. Minimize or avoid natural or artificial sunlight exposure. Actinic keratosis; other types of basal cell carcinoma including nodular & morpheaform (fibrosing or sclerosing) types; superficial basal cell carcinoma lesions on the face, head & anogenital area. Pregnancy & lactation. Childn.

Click to view Imiquad detailed prescribing information

Use In Pregnancy & Lactation

Click to view Imiquad detailed prescribing information

Adverse Reactions

Application site disorders, remote site reactions, fatigue, fever, flu-like symptoms, headache, diarrhea, myalgia.

Click to view Imiquad detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Imiquad detailed prescribing information

Storage

View Imiquad storage conditions for details to ensure optimal shelf-life.

Description

View Imiquad description for details of the chemical structure and excipients (inactive components).

Action

View Imiquad mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Warts & Calluses Preparations

ATC Classification

D06BB10 - imiquimod ; Belongs to the class of topical antivirals used in the treatment of dermatological diseases.

Regulatory Classification

Presentation/Packing

Form

Imiquad cream 5%

Packing/Price

250 mg x 3 × 1's (P926.25/box)

Imiquad

imiquimod

Manufacturer:

Glenmark

Distributor:

Glenmark